Cost-effectiveness of 12-month therapeutic assertive community treatment as part of integrated care versus standard care in patients with schizophrenia treated with quetiapine immediate release (ACCESS trial).

@article{Karow2012CosteffectivenessO1,
  title={Cost-effectiveness of 12-month therapeutic assertive community treatment as part of integrated care versus standard care in patients with schizophrenia treated with quetiapine immediate release (ACCESS trial).},
  author={Anne C. Karow and J. C. Reimer and Hans Helmut K{\"o}nig and Dirk Heider and Thomas Bock and Christian G Huber and Daniel Sch{\"o}ttle and Klara Meister and Liz Rietschel and Gunda Ohm and Holger Schulz and Dieter Naber and Benno Graf Schimmelmann and Martin Lambert},
  journal={The Journal of clinical psychiatry},
  year={2012},
  volume={73 3},
  pages={e402-8}
}
OBJECTIVE To compare the 1-year cost-effectiveness of therapeutic assertive community treatment (ACT) with standard care in schizophrenia. ACT was specifically developed for patients with schizophrenia, delivered by psychosis experts highly trained in respective psychotherapies, and embedded into an integrated care system. METHOD Two catchment areas in Hamburg, Germany, with similar population size and health care structures were assigned to offer 12-month ACT (n = 64) or standard care (n… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 23 extracted citations

Continuity across inpatient and outpatient mental health care or specialisation of teams? A systematic review.

European psychiatry : the journal of the Association of European Psychiatrists • 2015
View 11 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…